| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telomere | 60 | 2024 | 546 | 8.730 |
Why?
|
| Telomerase | 49 | 2024 | 543 | 6.660 |
Why?
|
| Forkhead Transcription Factors | 59 | 2018 | 771 | 4.250 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 22 | 2023 | 1409 | 3.710 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 50 | 2024 | 507 | 3.590 |
Why?
|
| Pancreatic Neoplasms | 43 | 2023 | 5248 | 3.500 |
Why?
|
| PTEN Phosphohydrolase | 23 | 2020 | 1014 | 3.410 |
Why?
|
| Carcinoma, Pancreatic Ductal | 25 | 2023 | 1825 | 3.260 |
Why?
|
| Cell Transformation, Neoplastic | 57 | 2021 | 2472 | 3.120 |
Why?
|
| Mice | 319 | 2024 | 36054 | 3.060 |
Why?
|
| Glioblastoma | 26 | 2021 | 1781 | 2.880 |
Why?
|
| Animals | 364 | 2024 | 62823 | 2.740 |
Why?
|
| DNA-Binding Proteins | 56 | 2023 | 5067 | 2.660 |
Why?
|
| Aging | 19 | 2024 | 1578 | 2.360 |
Why?
|
| Tumor Suppressor Protein p53 | 50 | 2019 | 3671 | 2.260 |
Why?
|
| Tumor Suppressor Protein p14ARF | 30 | 2007 | 101 | 2.190 |
Why?
|
| Tumor Microenvironment | 20 | 2023 | 3026 | 2.110 |
Why?
|
| Transcription Factors | 65 | 2023 | 5506 | 2.090 |
Why?
|
| Cell Differentiation | 52 | 2024 | 4195 | 2.070 |
Why?
|
| Genes, Tumor Suppressor | 30 | 2017 | 1132 | 1.940 |
Why?
|
| Gene Expression Regulation, Neoplastic | 47 | 2022 | 9101 | 1.860 |
Why?
|
| Repressor Proteins | 30 | 2013 | 1730 | 1.820 |
Why?
|
| Mice, Transgenic | 73 | 2023 | 4371 | 1.740 |
Why?
|
| Cellular Senescence | 23 | 2024 | 392 | 1.740 |
Why?
|
| Proto-Oncogene Proteins c-myc | 26 | 2016 | 845 | 1.730 |
Why?
|
| Tumor Suppressor Proteins | 37 | 2020 | 1904 | 1.680 |
Why?
|
| Prostatic Neoplasms | 16 | 2022 | 5996 | 1.670 |
Why?
|
| Genes, myc | 20 | 2017 | 375 | 1.640 |
Why?
|
| Colorectal Neoplasms | 11 | 2023 | 3704 | 1.620 |
Why?
|
| Oncogenes | 18 | 2020 | 701 | 1.600 |
Why?
|
| Signal Transduction | 68 | 2021 | 12223 | 1.560 |
Why?
|
| Stem Cells | 18 | 2024 | 1236 | 1.550 |
Why?
|
| Forkhead Box Protein O1 | 41 | 2021 | 166 | 1.490 |
Why?
|
| Neoplasms | 49 | 2023 | 15928 | 1.490 |
Why?
|
| Sex Characteristics | 2 | 2023 | 434 | 1.460 |
Why?
|
| Adaptor Proteins, Signal Transducing | 14 | 2020 | 1483 | 1.420 |
Why?
|
| Smad4 Protein | 5 | 2020 | 202 | 1.370 |
Why?
|
| Mice, Knockout | 87 | 2022 | 5841 | 1.360 |
Why?
|
| Brain Neoplasms | 22 | 2021 | 4993 | 1.350 |
Why?
|
| Genes, p53 | 18 | 2014 | 1146 | 1.340 |
Why?
|
| Cell Cycle Proteins | 33 | 2020 | 2129 | 1.190 |
Why?
|
| Tumor Escape | 2 | 2020 | 248 | 1.190 |
Why?
|
| Neoplastic Stem Cells | 11 | 2021 | 1469 | 1.170 |
Why?
|
| Mice, Inbred C57BL | 58 | 2024 | 7237 | 1.170 |
Why?
|
| Cells, Cultured | 69 | 2018 | 5788 | 1.160 |
Why?
|
| Humans | 252 | 2024 | 271941 | 1.140 |
Why?
|
| Disease Models, Animal | 42 | 2023 | 7476 | 1.130 |
Why?
|
| Cell Division | 40 | 2012 | 2711 | 1.130 |
Why?
|
| Adenomatous Polyposis Coli Protein | 3 | 2024 | 102 | 1.110 |
Why?
|
| Mitochondria | 12 | 2018 | 1314 | 1.110 |
Why?
|
| Cell Line, Tumor | 48 | 2021 | 14881 | 1.100 |
Why?
|
| Cell Cycle | 28 | 2014 | 2150 | 1.090 |
Why?
|
| Gene Deletion | 22 | 2017 | 1487 | 1.090 |
Why?
|
| Genes, p16 | 15 | 2010 | 132 | 1.070 |
Why?
|
| Apoptosis | 52 | 2023 | 7837 | 1.040 |
Why?
|
| Pancreas | 9 | 2017 | 746 | 1.010 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2023 | 116 | 1.000 |
Why?
|
| Transcription, Genetic | 33 | 2017 | 3417 | 1.000 |
Why?
|
| Gene Expression Regulation | 39 | 2021 | 4200 | 0.990 |
Why?
|
| Histone Demethylases | 2 | 2023 | 145 | 0.970 |
Why?
|
| Genes, ras | 19 | 2017 | 681 | 0.970 |
Why?
|
| Wnt Signaling Pathway | 6 | 2024 | 445 | 0.970 |
Why?
|
| Genes, Essential | 2 | 2017 | 57 | 0.970 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 6 | 2011 | 1547 | 0.960 |
Why?
|
| Glioma | 11 | 2020 | 1988 | 0.960 |
Why?
|
| Muscle Proteins | 8 | 2014 | 561 | 0.950 |
Why?
|
| Myeloid Cells | 5 | 2022 | 277 | 0.950 |
Why?
|
| Proteins | 26 | 2012 | 2058 | 0.910 |
Why?
|
| Neoplasms, Experimental | 12 | 2007 | 790 | 0.900 |
Why?
|
| Forkhead Box Protein O3 | 26 | 2021 | 109 | 0.890 |
Why?
|
| Gene Expression Regulation, Developmental | 16 | 2015 | 1524 | 0.890 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2021 | 224 | 0.890 |
Why?
|
| Nuclear Proteins | 22 | 2015 | 3472 | 0.890 |
Why?
|
| Saccharomyces cerevisiae Proteins | 9 | 2004 | 473 | 0.880 |
Why?
|
| Fibroblasts | 33 | 2023 | 1670 | 0.860 |
Why?
|
| Oxidoreductases, N-Demethylating | 2 | 2021 | 41 | 0.860 |
Why?
|
| Synthetic Lethal Mutations | 2 | 2019 | 32 | 0.820 |
Why?
|
| Dioxygenases | 2 | 2022 | 171 | 0.820 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2023 | 117 | 0.810 |
Why?
|
| DNA Damage | 21 | 2024 | 1989 | 0.780 |
Why?
|
| Liver | 21 | 2015 | 3124 | 0.780 |
Why?
|
| RNA | 15 | 2011 | 1072 | 0.760 |
Why?
|
| Homeostasis | 19 | 2013 | 959 | 0.750 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2021 | 114 | 0.740 |
Why?
|
| Health | 1 | 2021 | 51 | 0.730 |
Why?
|
| Cytokines | 8 | 2021 | 2841 | 0.730 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2022 | 227 | 0.730 |
Why?
|
| CLOCK Proteins | 1 | 2020 | 33 | 0.700 |
Why?
|
| ARNTL Transcription Factors | 1 | 2020 | 52 | 0.700 |
Why?
|
| Adenocarcinoma | 20 | 2022 | 7976 | 0.700 |
Why?
|
| Histone Deacetylases | 11 | 2013 | 366 | 0.690 |
Why?
|
| Carrier Proteins | 17 | 2017 | 2139 | 0.680 |
Why?
|
| RNA-Binding Proteins | 6 | 2013 | 1026 | 0.680 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2019 | 12 | 0.680 |
Why?
|
| Cell Proliferation | 33 | 2023 | 7302 | 0.680 |
Why?
|
| NF-kappa B | 6 | 2017 | 1569 | 0.670 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2019 | 7 | 0.670 |
Why?
|
| Mutation | 44 | 2021 | 15941 | 0.670 |
Why?
|
| Neoplasm Invasiveness | 10 | 2017 | 4071 | 0.660 |
Why?
|
| Gene Expression Profiling | 22 | 2021 | 5187 | 0.650 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2021 | 342 | 0.650 |
Why?
|
| ErbB Receptors | 11 | 2012 | 2383 | 0.650 |
Why?
|
| Mice, SCID | 16 | 2020 | 1851 | 0.650 |
Why?
|
| Mice, Mutant Strains | 18 | 2020 | 664 | 0.650 |
Why?
|
| Hematopoiesis | 7 | 2015 | 608 | 0.640 |
Why?
|
| Paracrine Communication | 1 | 2019 | 130 | 0.630 |
Why?
|
| Promoter Regions, Genetic | 23 | 2024 | 3262 | 0.630 |
Why?
|
| Immunity | 1 | 2021 | 356 | 0.630 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2021 | 356 | 0.610 |
Why?
|
| Cell Communication | 1 | 2021 | 518 | 0.610 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2017 | 20 | 0.610 |
Why?
|
| Chromosomal Instability | 5 | 2007 | 230 | 0.600 |
Why?
|
| Oncogene Protein p21(ras) | 2 | 2014 | 48 | 0.590 |
Why?
|
| Malate Dehydrogenase | 1 | 2017 | 20 | 0.570 |
Why?
|
| Lysine | 4 | 2017 | 428 | 0.560 |
Why?
|
| DNA Helicases | 3 | 2017 | 451 | 0.550 |
Why?
|
| Proto-Oncogene Proteins | 17 | 2014 | 2624 | 0.550 |
Why?
|
| Biomarkers, Tumor | 9 | 2021 | 10750 | 0.550 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 229 | 0.540 |
Why?
|
| DNA-Activated Protein Kinase | 2 | 2006 | 76 | 0.540 |
Why?
|
| Genome, Human | 6 | 2011 | 1885 | 0.540 |
Why?
|
| Colonic Neoplasms | 2 | 2023 | 1443 | 0.540 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2016 | 461 | 0.540 |
Why?
|
| Chemokine CXCL5 | 1 | 2015 | 14 | 0.530 |
Why?
|
| DNA Repair | 13 | 2017 | 1912 | 0.530 |
Why?
|
| Genomics | 7 | 2019 | 2830 | 0.530 |
Why?
|
| Nerve Tissue Proteins | 10 | 2013 | 1598 | 0.530 |
Why?
|
| Glycoproteins | 1 | 2020 | 792 | 0.530 |
Why?
|
| Ubiquitin-Protein Ligases | 5 | 2015 | 882 | 0.530 |
Why?
|
| Molecular Sequence Data | 38 | 2013 | 6782 | 0.520 |
Why?
|
| Disease Progression | 18 | 2022 | 6910 | 0.520 |
Why?
|
| Male | 74 | 2024 | 128995 | 0.520 |
Why?
|
| Enzyme Inhibitors | 11 | 2020 | 1966 | 0.520 |
Why?
|
| Phosphoproteins | 7 | 2017 | 1230 | 0.520 |
Why?
|
| Receptors, Androgen | 1 | 2021 | 909 | 0.520 |
Why?
|
| Chromosome Aberrations | 14 | 2013 | 2034 | 0.510 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 2 | 2018 | 469 | 0.510 |
Why?
|
| Neurons | 11 | 2021 | 2461 | 0.510 |
Why?
|
| Cystadenoma, Serous | 2 | 2008 | 31 | 0.500 |
Why?
|
| Cell Lineage | 10 | 2012 | 706 | 0.500 |
Why?
|
| Astrocytes | 7 | 2012 | 406 | 0.500 |
Why?
|
| Neoplasm Metastasis | 10 | 2021 | 5330 | 0.500 |
Why?
|
| Myeloid-Derived Suppressor Cells | 4 | 2021 | 103 | 0.500 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 5 | 2022 | 437 | 0.490 |
Why?
|
| DNA Methylation | 3 | 2024 | 2761 | 0.490 |
Why?
|
| Phosphorylation | 21 | 2021 | 4984 | 0.490 |
Why?
|
| Phenotype | 32 | 2021 | 6516 | 0.490 |
Why?
|
| MAP Kinase Kinase Kinase 2 | 1 | 2014 | 14 | 0.480 |
Why?
|
| Cell Line | 18 | 2020 | 5433 | 0.480 |
Why?
|
| Hematopoietic Stem Cells | 9 | 2011 | 1373 | 0.480 |
Why?
|
| Osteoblasts | 7 | 2013 | 394 | 0.480 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 294 | 0.470 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 830 | 0.470 |
Why?
|
| Insulin | 12 | 2015 | 1508 | 0.460 |
Why?
|
| Multiple Myeloma | 6 | 2019 | 2286 | 0.460 |
Why?
|
| Programmed Cell Death 1 Receptor | 3 | 2022 | 1091 | 0.450 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2014 | 188 | 0.440 |
Why?
|
| Cell Survival | 14 | 2014 | 3074 | 0.440 |
Why?
|
| Transcriptional Activation | 9 | 2021 | 1146 | 0.440 |
Why?
|
| Genome | 11 | 2011 | 690 | 0.440 |
Why?
|
| Longevity | 4 | 2008 | 155 | 0.430 |
Why?
|
| Carboxylic Ester Hydrolases | 2 | 2003 | 17 | 0.430 |
Why?
|
| Multigene Family | 10 | 2006 | 465 | 0.420 |
Why?
|
| Inflammation | 4 | 2020 | 2534 | 0.420 |
Why?
|
| Macrophages | 1 | 2019 | 1377 | 0.420 |
Why?
|
| Phosphopyruvate Hydratase | 3 | 2020 | 90 | 0.420 |
Why?
|
| Wnt Proteins | 4 | 2013 | 392 | 0.410 |
Why?
|
| Glucose | 12 | 2015 | 1245 | 0.410 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 14 | 2012 | 636 | 0.410 |
Why?
|
| Stress, Physiological | 5 | 2016 | 494 | 0.410 |
Why?
|
| Neurogenesis | 3 | 2024 | 240 | 0.410 |
Why?
|
| Sequence Deletion | 4 | 2020 | 915 | 0.410 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2021 | 1295 | 0.400 |
Why?
|
| F-Box Proteins | 2 | 2011 | 99 | 0.400 |
Why?
|
| alpha-Crystallin B Chain | 2 | 2008 | 4 | 0.400 |
Why?
|
| Multipotent Stem Cells | 2 | 2009 | 54 | 0.400 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2011 | 703 | 0.390 |
Why?
|
| Telomere Homeostasis | 1 | 2012 | 76 | 0.390 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 4 | 2024 | 162 | 0.390 |
Why?
|
| Intestinal Mucosa | 4 | 2021 | 1125 | 0.390 |
Why?
|
| RNA Stability | 1 | 2012 | 135 | 0.390 |
Why?
|
| Caspase Inhibitors | 2 | 2011 | 96 | 0.390 |
Why?
|
| High Mobility Group Proteins | 1 | 2011 | 65 | 0.390 |
Why?
|
| Endoplasmic Reticulum | 4 | 2013 | 334 | 0.390 |
Why?
|
| Genomic Instability | 6 | 2021 | 522 | 0.390 |
Why?
|
| Prostate | 6 | 2022 | 1138 | 0.390 |
Why?
|
| Conserved Sequence | 5 | 2011 | 499 | 0.380 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2011 | 42 | 0.380 |
Why?
|
| Recombination, Genetic | 6 | 2008 | 668 | 0.380 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 11 | 2013 | 63 | 0.380 |
Why?
|
| Caspases, Effector | 1 | 2011 | 4 | 0.380 |
Why?
|
| Models, Biological | 16 | 2022 | 3223 | 0.380 |
Why?
|
| Carcinogenesis | 5 | 2022 | 1037 | 0.380 |
Why?
|
| Amino Acid Sequence | 25 | 2011 | 4635 | 0.380 |
Why?
|
| Schools, Medical | 1 | 2012 | 132 | 0.370 |
Why?
|
| Interleukin-18 | 2 | 2021 | 91 | 0.370 |
Why?
|
| Phosphatidylinositol 3-Kinases | 12 | 2015 | 1720 | 0.370 |
Why?
|
| Gene Expression | 18 | 2013 | 3689 | 0.360 |
Why?
|
| Antineoplastic Agents | 10 | 2020 | 14653 | 0.360 |
Why?
|
| RNA, Small Interfering | 14 | 2017 | 2219 | 0.360 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2022 | 595 | 0.360 |
Why?
|
| Enzyme Activation | 15 | 2021 | 1832 | 0.360 |
Why?
|
| Lipids | 4 | 2023 | 662 | 0.360 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 2 | 2007 | 72 | 0.360 |
Why?
|
| Chromosomes | 6 | 2006 | 324 | 0.360 |
Why?
|
| Peutz-Jeghers Syndrome | 4 | 2008 | 59 | 0.360 |
Why?
|
| Lymphoma, T-Cell | 3 | 2012 | 369 | 0.350 |
Why?
|
| Chromatin | 4 | 2013 | 1050 | 0.350 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2015 | 685 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-akt | 13 | 2021 | 2085 | 0.350 |
Why?
|
| Colon | 3 | 2021 | 691 | 0.350 |
Why?
|
| Embryonic and Fetal Development | 5 | 2000 | 229 | 0.350 |
Why?
|
| Cell Movement | 6 | 2019 | 2504 | 0.350 |
Why?
|
| Base Sequence | 25 | 2013 | 5500 | 0.340 |
Why?
|
| Caspase 7 | 2 | 2008 | 33 | 0.340 |
Why?
|
| Molecular Targeted Therapy | 3 | 2017 | 2400 | 0.340 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 1335 | 0.330 |
Why?
|
| Brain | 10 | 2024 | 4252 | 0.330 |
Why?
|
| Ubiquitination | 3 | 2019 | 577 | 0.330 |
Why?
|
| RNA Interference | 13 | 2017 | 1397 | 0.330 |
Why?
|
| Histone Deacetylase 2 | 4 | 2022 | 36 | 0.330 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2013 | 557 | 0.320 |
Why?
|
| Energy Metabolism | 9 | 2018 | 1004 | 0.320 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2021 | 1614 | 0.320 |
Why?
|
| RNA Splicing | 4 | 2017 | 362 | 0.320 |
Why?
|
| Microtubule-Associated Proteins | 9 | 2015 | 533 | 0.320 |
Why?
|
| Werner Syndrome | 3 | 2005 | 12 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2013 | 5755 | 0.320 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 13 | 2011 | 253 | 0.320 |
Why?
|
| Gluconeogenesis | 6 | 2015 | 129 | 0.320 |
Why?
|
| Sirtuins | 4 | 2013 | 43 | 0.320 |
Why?
|
| Oxidative Stress | 7 | 2010 | 1159 | 0.320 |
Why?
|
| Astrocytoma | 3 | 2007 | 335 | 0.320 |
Why?
|
| Drug Design | 2 | 2012 | 378 | 0.310 |
Why?
|
| Caspase 3 | 2 | 2013 | 481 | 0.310 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 5421 | 0.310 |
Why?
|
| Up-Regulation | 10 | 2023 | 2457 | 0.310 |
Why?
|
| Necrosis | 3 | 2008 | 604 | 0.310 |
Why?
|
| Melanoma | 12 | 2011 | 5592 | 0.310 |
Why?
|
| p21-Activated Kinases | 1 | 2008 | 132 | 0.310 |
Why?
|
| DNA Ligases | 3 | 2006 | 67 | 0.310 |
Why?
|
| Oxidative Phosphorylation | 3 | 2019 | 267 | 0.310 |
Why?
|
| Pancreatic Ducts | 1 | 2008 | 128 | 0.300 |
Why?
|
| Immunotherapy | 3 | 2021 | 3546 | 0.300 |
Why?
|
| TOR Serine-Threonine Kinases | 11 | 2015 | 1575 | 0.300 |
Why?
|
| Multiprotein Complexes | 7 | 2016 | 389 | 0.300 |
Why?
|
| AMP-Activated Protein Kinases | 9 | 2017 | 409 | 0.300 |
Why?
|
| Transfection | 17 | 2020 | 3166 | 0.300 |
Why?
|
| Intestinal Polyps | 3 | 2008 | 75 | 0.300 |
Why?
|
| 3T3 Cells | 8 | 2007 | 387 | 0.300 |
Why?
|
| Female | 56 | 2023 | 149187 | 0.300 |
Why?
|
| Autophagy | 7 | 2018 | 922 | 0.290 |
Why?
|
| Membrane Glycoproteins | 5 | 2013 | 1105 | 0.290 |
Why?
|
| Reactive Oxygen Species | 7 | 2017 | 1011 | 0.290 |
Why?
|
| Receptors, Interleukin-8B | 2 | 2019 | 58 | 0.290 |
Why?
|
| Integrases | 8 | 2015 | 266 | 0.290 |
Why?
|
| Cyclin-Dependent Kinases | 10 | 2003 | 322 | 0.290 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2008 | 180 | 0.290 |
Why?
|
| ras Proteins | 7 | 2014 | 802 | 0.290 |
Why?
|
| Translocation, Genetic | 4 | 2001 | 1288 | 0.290 |
Why?
|
| Xenograft Model Antitumor Assays | 9 | 2020 | 3929 | 0.290 |
Why?
|
| Helix-Loop-Helix Motifs | 6 | 2000 | 64 | 0.290 |
Why?
|
| Lens, Crystalline | 7 | 1998 | 163 | 0.290 |
Why?
|
| Adenoma | 3 | 2024 | 745 | 0.280 |
Why?
|
| Models, Genetic | 9 | 2007 | 1168 | 0.280 |
Why?
|
| Myocytes, Cardiac | 5 | 2021 | 710 | 0.280 |
Why?
|
| Extracellular Matrix | 3 | 2021 | 534 | 0.280 |
Why?
|
| Leptin | 4 | 2018 | 312 | 0.280 |
Why?
|
| Histiocytic Disorders, Malignant | 1 | 2006 | 7 | 0.270 |
Why?
|
| Retinoblastoma Protein | 7 | 2001 | 342 | 0.270 |
Why?
|
| Endothelium, Vascular | 5 | 2013 | 898 | 0.270 |
Why?
|
| Transforming Growth Factor beta | 7 | 2017 | 1133 | 0.270 |
Why?
|
| Cell Line, Transformed | 8 | 2008 | 431 | 0.270 |
Why?
|
| Tumor Cells, Cultured | 15 | 2017 | 5804 | 0.270 |
Why?
|
| Crosses, Genetic | 9 | 2015 | 257 | 0.270 |
Why?
|
| Plasma Cells | 1 | 2007 | 201 | 0.270 |
Why?
|
| Embryo, Mammalian | 10 | 2008 | 758 | 0.270 |
Why?
|
| Protein Binding | 14 | 2016 | 3528 | 0.260 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2004 | 689 | 0.260 |
Why?
|
| Genes, Retinoblastoma | 6 | 2005 | 93 | 0.260 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 3 | 2014 | 45 | 0.260 |
Why?
|
| Genotype | 8 | 2017 | 4266 | 0.260 |
Why?
|
| Gene Knockdown Techniques | 5 | 2021 | 1085 | 0.260 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2008 | 233 | 0.250 |
Why?
|
| Immunohistochemistry | 13 | 2020 | 7827 | 0.250 |
Why?
|
| Nucleic Acid Hybridization | 7 | 2007 | 632 | 0.250 |
Why?
|
| Cloning, Molecular | 9 | 2002 | 1458 | 0.250 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2006 | 191 | 0.250 |
Why?
|
| Osteopontin | 2 | 2019 | 148 | 0.250 |
Why?
|
| Mice, Nude | 12 | 2020 | 4359 | 0.250 |
Why?
|
| Chimera | 4 | 2017 | 152 | 0.250 |
Why?
|
| Genes, cdc | 4 | 2012 | 84 | 0.250 |
Why?
|
| Heterografts | 4 | 2021 | 745 | 0.240 |
Why?
|
| Glycolysis | 6 | 2020 | 534 | 0.240 |
Why?
|
| Lymphocytes | 6 | 2007 | 1280 | 0.240 |
Why?
|
| T-Lymphocytes | 11 | 2021 | 3947 | 0.240 |
Why?
|
| Protein Stability | 3 | 2017 | 376 | 0.240 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 1659 | 0.240 |
Why?
|
| HEK293 Cells | 6 | 2019 | 1470 | 0.240 |
Why?
|
| Sequence Homology, Amino Acid | 8 | 2002 | 1093 | 0.240 |
Why?
|
| Transcriptome | 5 | 2021 | 1950 | 0.240 |
Why?
|
| Homozygote | 8 | 2012 | 771 | 0.240 |
Why?
|
| Fungal Proteins | 4 | 2004 | 272 | 0.240 |
Why?
|
| Serine Endopeptidases | 2 | 2017 | 280 | 0.240 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2006 | 333 | 0.230 |
Why?
|
| Endothelial Cells | 4 | 2016 | 1048 | 0.230 |
Why?
|
| Neoplasm Proteins | 8 | 2010 | 3363 | 0.230 |
Why?
|
| Methylation | 3 | 2017 | 626 | 0.230 |
Why?
|
| Muscle, Skeletal | 9 | 2015 | 1313 | 0.230 |
Why?
|
| Neoplasms, Glandular and Epithelial | 3 | 2007 | 522 | 0.230 |
Why?
|
| B-Lymphocytes | 8 | 2009 | 1429 | 0.230 |
Why?
|
| Cell Plasticity | 2 | 2021 | 67 | 0.220 |
Why?
|
| Atherosclerosis | 2 | 2012 | 957 | 0.220 |
Why?
|
| Heterochromatin | 1 | 2003 | 90 | 0.220 |
Why?
|
| Muscular Atrophy | 2 | 2015 | 107 | 0.220 |
Why?
|
| Haplotypes | 1 | 2006 | 909 | 0.220 |
Why?
|
| Viral Proteins | 6 | 2008 | 493 | 0.220 |
Why?
|
| Neuregulin-1 | 1 | 2023 | 89 | 0.220 |
Why?
|
| Chromosome Segregation | 1 | 2003 | 84 | 0.220 |
Why?
|
| Osteogenesis | 4 | 2015 | 271 | 0.220 |
Why?
|
| Databases, Genetic | 3 | 2021 | 751 | 0.220 |
Why?
|
| Transcription Factor AP-1 | 1 | 2024 | 252 | 0.220 |
Why?
|
| Lymphocyte Activation | 5 | 2013 | 1728 | 0.220 |
Why?
|
| Sarcoma | 2 | 2006 | 1842 | 0.220 |
Why?
|
| Cell Nucleolus | 2 | 2002 | 102 | 0.220 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2022 | 17 | 0.220 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2013 | 2496 | 0.220 |
Why?
|
| Melanocytes | 6 | 2010 | 241 | 0.210 |
Why?
|
| CDC2-CDC28 Kinases | 2 | 2000 | 132 | 0.210 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 6 | 2012 | 14 | 0.210 |
Why?
|
| Tryptophan Oxygenase | 1 | 2022 | 9 | 0.210 |
Why?
|
| RNA, Messenger | 20 | 2009 | 6489 | 0.210 |
Why?
|
| Muscle Development | 3 | 2012 | 88 | 0.210 |
Why?
|
| Mutagenesis, Insertional | 2 | 2002 | 219 | 0.210 |
Why?
|
| RNA Splicing Factors | 2 | 2013 | 154 | 0.210 |
Why?
|
| Neovascularization, Physiologic | 3 | 2013 | 357 | 0.210 |
Why?
|
| Lung Neoplasms | 9 | 2011 | 12012 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2007 | 1435 | 0.210 |
Why?
|
| Skin Neoplasms | 7 | 2011 | 4889 | 0.210 |
Why?
|
| Biological Evolution | 2 | 1994 | 293 | 0.210 |
Why?
|
| Rats | 20 | 2010 | 6640 | 0.210 |
Why?
|
| Ovarian Follicle | 1 | 2003 | 144 | 0.210 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2013 | 716 | 0.210 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2024 | 263 | 0.210 |
Why?
|
| CD47 Antigen | 1 | 2022 | 27 | 0.200 |
Why?
|
| Interleukin-33 | 1 | 2022 | 19 | 0.200 |
Why?
|
| Acute Pain | 1 | 2022 | 49 | 0.200 |
Why?
|
| Mycobiome | 1 | 2022 | 12 | 0.200 |
Why?
|
| Luciferases | 7 | 2010 | 464 | 0.200 |
Why?
|
| Organoids | 2 | 2022 | 327 | 0.200 |
Why?
|
| DNA Replication | 6 | 2017 | 772 | 0.200 |
Why?
|
| Gene Amplification | 2 | 2002 | 770 | 0.200 |
Why?
|
| Tryptophan | 1 | 2022 | 144 | 0.200 |
Why?
|
| MicroRNAs | 2 | 2012 | 2913 | 0.200 |
Why?
|
| Radiation Tolerance | 4 | 2017 | 636 | 0.200 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2021 | 35 | 0.200 |
Why?
|
| Histones | 6 | 2022 | 1514 | 0.200 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2024 | 320 | 0.200 |
Why?
|
| Thymus Gland | 6 | 2010 | 312 | 0.190 |
Why?
|
| Organ Specificity | 10 | 2013 | 755 | 0.190 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2015 | 3148 | 0.190 |
Why?
|
| Gene Targeting | 7 | 2012 | 321 | 0.190 |
Why?
|
| Cardiomegaly, Exercise-Induced | 1 | 2021 | 2 | 0.190 |
Why?
|
| Bile Duct Neoplasms | 1 | 2006 | 498 | 0.190 |
Why?
|
| Cardiomegaly | 2 | 2021 | 181 | 0.190 |
Why?
|
| Blotting, Western | 11 | 2013 | 3646 | 0.190 |
Why?
|
| Cholangiocarcinoma | 1 | 2006 | 501 | 0.190 |
Why?
|
| Bone Remodeling | 2 | 2012 | 102 | 0.190 |
Why?
|
| Peptide Synthases | 1 | 2000 | 9 | 0.190 |
Why?
|
| beta Catenin | 3 | 2022 | 691 | 0.180 |
Why?
|
| Culture Media | 1 | 2021 | 349 | 0.180 |
Why?
|
| Caspase 1 | 1 | 2020 | 63 | 0.180 |
Why?
|
| Cullin Proteins | 1 | 2000 | 39 | 0.180 |
Why?
|
| Multienzyme Complexes | 4 | 2005 | 228 | 0.180 |
Why?
|
| STAT3 Transcription Factor | 4 | 2018 | 1146 | 0.180 |
Why?
|
| E2F Transcription Factors | 4 | 2014 | 138 | 0.180 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 2000 | 18 | 0.180 |
Why?
|
| Catalytic Domain | 5 | 2006 | 306 | 0.180 |
Why?
|
| Cell Culture Techniques | 2 | 2021 | 584 | 0.180 |
Why?
|
| Ubiquitins | 1 | 2000 | 100 | 0.180 |
Why?
|
| Cyclin D1 | 6 | 2014 | 594 | 0.180 |
Why?
|
| Spermatogonia | 2 | 2012 | 160 | 0.180 |
Why?
|
| Neoplasm Transplantation | 5 | 2013 | 1566 | 0.170 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 231 | 0.170 |
Why?
|
| NADP | 2 | 2017 | 92 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2015 | 4964 | 0.170 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2019 | 9 | 0.170 |
Why?
|
| Histone Deacetylase 1 | 4 | 2010 | 63 | 0.170 |
Why?
|
| Radiation, Ionizing | 1 | 2000 | 192 | 0.170 |
Why?
|
| Leukemia, Experimental | 1 | 1999 | 83 | 0.170 |
Why?
|
| Alleles | 7 | 2009 | 2599 | 0.170 |
Why?
|
| Cell Self Renewal | 1 | 2020 | 69 | 0.170 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2019 | 15 | 0.170 |
Why?
|
| Ketoglutaric Acids | 2 | 2017 | 44 | 0.170 |
Why?
|
| Nervous System Diseases | 1 | 2004 | 522 | 0.170 |
Why?
|
| Acetylation | 7 | 2013 | 517 | 0.170 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 5 | 2014 | 276 | 0.170 |
Why?
|
| THP-1 Cells | 1 | 2019 | 55 | 0.170 |
Why?
|
| Intestines | 1 | 2024 | 740 | 0.170 |
Why?
|
| RAW 264.7 Cells | 1 | 2019 | 58 | 0.170 |
Why?
|
| Trans-Activators | 7 | 2009 | 1660 | 0.170 |
Why?
|
| ADP-Ribosylation Factors | 3 | 2019 | 32 | 0.170 |
Why?
|
| Germ-Line Mutation | 5 | 2009 | 1102 | 0.170 |
Why?
|
| Cellular Reprogramming | 2 | 2020 | 202 | 0.170 |
Why?
|
| Serotonin | 2 | 2012 | 290 | 0.170 |
Why?
|
| Lymphoma | 8 | 2007 | 1514 | 0.170 |
Why?
|
| Phosphogluconate Dehydrogenase | 1 | 2019 | 9 | 0.170 |
Why?
|
| Pinocytosis | 1 | 2019 | 28 | 0.170 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1999 | 71 | 0.170 |
Why?
|
| Intestinal Neoplasms | 1 | 2001 | 202 | 0.170 |
Why?
|
| Liver Regeneration | 1 | 2000 | 134 | 0.160 |
Why?
|
| Syndecan-1 | 1 | 2019 | 52 | 0.160 |
Why?
|
| Protein Precursors | 1 | 2020 | 252 | 0.160 |
Why?
|
| Isoenzymes | 3 | 2017 | 663 | 0.160 |
Why?
|
| Pyruvate Kinase | 2 | 2022 | 33 | 0.160 |
Why?
|
| Insulin Receptor Substrate Proteins | 4 | 2012 | 145 | 0.160 |
Why?
|
| Biocatalysis | 2 | 2017 | 64 | 0.160 |
Why?
|
| Neuralgia | 1 | 2022 | 264 | 0.160 |
Why?
|
| Intestine, Small | 2 | 2021 | 527 | 0.160 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2019 | 57 | 0.160 |
Why?
|
| Cyclins | 6 | 2001 | 470 | 0.160 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2017 | 218 | 0.160 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 246 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 3 | 2005 | 265 | 0.160 |
Why?
|
| Chronic Pain | 1 | 2022 | 262 | 0.160 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2018 | 88 | 0.160 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2021 | 531 | 0.160 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2018 | 40 | 0.160 |
Why?
|
| Chemokines, CXC | 1 | 2019 | 129 | 0.160 |
Why?
|
| Precancerous Conditions | 1 | 2005 | 1065 | 0.160 |
Why?
|
| Affect | 2 | 2018 | 306 | 0.160 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 1999 | 72 | 0.160 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 910 | 0.160 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2018 | 257 | 0.160 |
Why?
|
| Integrin beta1 | 1 | 2019 | 132 | 0.160 |
Why?
|
| Research | 1 | 2021 | 431 | 0.160 |
Why?
|
| Quinazolines | 4 | 2012 | 953 | 0.160 |
Why?
|
| In Situ Hybridization, Fluorescence | 6 | 2007 | 2317 | 0.160 |
Why?
|
| Morphogenesis | 2 | 2018 | 336 | 0.160 |
Why?
|
| Nucleoproteins | 1 | 1998 | 37 | 0.160 |
Why?
|
| Immune Tolerance | 2 | 2018 | 431 | 0.150 |
Why?
|
| Microglia | 1 | 2020 | 176 | 0.150 |
Why?
|
| Sumoylation | 1 | 2018 | 81 | 0.150 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2010 | 2417 | 0.150 |
Why?
|
| Proteolysis | 2 | 2017 | 380 | 0.150 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2018 | 97 | 0.150 |
Why?
|
| Species Specificity | 4 | 2009 | 810 | 0.150 |
Why?
|
| Protein Kinases | 6 | 2008 | 919 | 0.150 |
Why?
|
| Penile Neoplasms | 1 | 2020 | 182 | 0.150 |
Why?
|
| Structure-Activity Relationship | 6 | 2020 | 1005 | 0.150 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2018 | 294 | 0.150 |
Why?
|
| Health Planning | 1 | 2017 | 31 | 0.150 |
Why?
|
| Neural Stem Cells | 3 | 2016 | 185 | 0.150 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 442 | 0.150 |
Why?
|
| Synthetic Biology | 1 | 2017 | 16 | 0.150 |
Why?
|
| Health Priorities | 1 | 2017 | 45 | 0.150 |
Why?
|
| Nuclear Factor 45 Protein | 1 | 2017 | 12 | 0.150 |
Why?
|
| Transplantation, Heterologous | 4 | 2013 | 1086 | 0.150 |
Why?
|
| Models, Animal | 4 | 2018 | 675 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 680 | 0.150 |
Why?
|
| RNA, Untranslated | 2 | 2005 | 242 | 0.150 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2017 | 87 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2022 | 690 | 0.150 |
Why?
|
| Chromosome Deletion | 2 | 2001 | 1055 | 0.150 |
Why?
|
| Protein Biosynthesis | 3 | 2010 | 1035 | 0.150 |
Why?
|
| Myofibroblasts | 1 | 2018 | 103 | 0.140 |
Why?
|
| Gene Editing | 1 | 2020 | 231 | 0.140 |
Why?
|
| Microcirculation | 2 | 2009 | 195 | 0.140 |
Why?
|
| NADPH Oxidase 4 | 1 | 2017 | 21 | 0.140 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2005 | 5566 | 0.140 |
Why?
|
| Restriction Mapping | 7 | 1999 | 336 | 0.140 |
Why?
|
| Prostate-Specific Antigen | 2 | 2011 | 1039 | 0.140 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2017 | 41 | 0.140 |
Why?
|
| Retroviridae | 4 | 2002 | 376 | 0.140 |
Why?
|
| Th17 Cells | 1 | 2018 | 163 | 0.140 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 40 | 0.140 |
Why?
|
| Gene Fusion | 1 | 2018 | 214 | 0.140 |
Why?
|
| Pregnancy Proteins | 1 | 2017 | 43 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatases | 3 | 2009 | 193 | 0.140 |
Why?
|
| Mutagenesis | 6 | 2013 | 524 | 0.140 |
Why?
|
| Testis | 5 | 2012 | 753 | 0.140 |
Why?
|
| Telomere Shortening | 2 | 2020 | 56 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2018 | 255 | 0.140 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 327 | 0.140 |
Why?
|
| Wnt-5a Protein | 1 | 2016 | 46 | 0.140 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2017 | 599 | 0.140 |
Why?
|
| Prognosis | 6 | 2022 | 22550 | 0.140 |
Why?
|
| Transaminases | 1 | 2017 | 82 | 0.140 |
Why?
|
| Mesoderm | 2 | 2017 | 397 | 0.140 |
Why?
|
| Carbon Tetrachloride Poisoning | 2 | 2006 | 13 | 0.140 |
Why?
|
| Interleukin-17 | 1 | 2018 | 257 | 0.140 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 3153 | 0.140 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2010 | 181 | 0.140 |
Why?
|
| Pyrrolidinones | 1 | 2016 | 62 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 353 | 0.140 |
Why?
|
| Receptor, Notch1 | 2 | 2008 | 220 | 0.140 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2017 | 103 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2013 | 473 | 0.140 |
Why?
|
| Osteocalcin | 3 | 2013 | 94 | 0.130 |
Why?
|
| Gene Dosage | 4 | 2011 | 829 | 0.130 |
Why?
|
| Genetic Therapy | 3 | 2002 | 1739 | 0.130 |
Why?
|
| Organophosphonates | 1 | 2016 | 63 | 0.130 |
Why?
|
| Tumor Burden | 2 | 2019 | 2035 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 1015 | 0.130 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 2 | 2014 | 48 | 0.130 |
Why?
|
| Proteome | 2 | 2011 | 573 | 0.130 |
Why?
|
| DNA Ligase ATP | 3 | 2006 | 53 | 0.130 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2018 | 173 | 0.130 |
Why?
|
| DNA Fragmentation | 3 | 2008 | 208 | 0.130 |
Why?
|
| Gastrointestinal Tract | 3 | 2012 | 326 | 0.130 |
Why?
|
| Cognition | 1 | 2021 | 982 | 0.130 |
Why?
|
| Exons | 8 | 2013 | 1388 | 0.130 |
Why?
|
| Precision Medicine | 4 | 2022 | 1207 | 0.130 |
Why?
|
| Sequence Alignment | 5 | 2011 | 883 | 0.130 |
Why?
|
| Islets of Langerhans | 2 | 2008 | 241 | 0.130 |
Why?
|
| Peptides | 4 | 2008 | 1529 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 617 | 0.130 |
Why?
|
| DNA Primers | 6 | 2012 | 1513 | 0.130 |
Why?
|
| Neuroendocrine Cells | 2 | 2012 | 18 | 0.130 |
Why?
|
| Protein Kinase C | 1 | 2017 | 419 | 0.130 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2015 | 84 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2013 | 682 | 0.130 |
Why?
|
| Homeodomain Proteins | 5 | 2018 | 1134 | 0.120 |
Why?
|
| Lysosomes | 3 | 2015 | 346 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 10 | 2010 | 1668 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2013 | 3651 | 0.120 |
Why?
|
| Chondrocytes | 1 | 2015 | 100 | 0.120 |
Why?
|
| Eye Neoplasms | 1 | 1997 | 257 | 0.120 |
Why?
|
| Bone Marrow | 4 | 2019 | 2446 | 0.120 |
Why?
|
| Genetic Engineering | 4 | 2012 | 298 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 3 | 2007 | 428 | 0.120 |
Why?
|
| In Vitro Techniques | 5 | 2004 | 1742 | 0.120 |
Why?
|
| Melanoma, Experimental | 3 | 2002 | 385 | 0.120 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 116 | 0.120 |
Why?
|
| Bone and Bones | 2 | 2015 | 613 | 0.120 |
Why?
|
| Dendritic Cells | 2 | 2013 | 1113 | 0.120 |
Why?
|
| Myogenic Regulatory Factors | 2 | 2012 | 32 | 0.120 |
Why?
|
| Anilides | 1 | 2017 | 296 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 4 | 2012 | 544 | 0.120 |
Why?
|
| Genes, Reporter | 4 | 2012 | 832 | 0.120 |
Why?
|
| Wound Healing | 4 | 2004 | 760 | 0.120 |
Why?
|
| Cyclooxygenase 2 | 2 | 2007 | 498 | 0.120 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2013 | 173 | 0.120 |
Why?
|
| Insulin-Secreting Cells | 3 | 2012 | 165 | 0.120 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2011 | 19 | 0.120 |
Why?
|
| Denervation | 1 | 2014 | 36 | 0.120 |
Why?
|
| Heterozygote | 8 | 2005 | 1057 | 0.120 |
Why?
|
| Sequence Homology, Nucleic Acid | 6 | 1999 | 422 | 0.110 |
Why?
|
| Cathepsin E | 1 | 2013 | 6 | 0.110 |
Why?
|
| Carbon Tetrachloride | 2 | 2006 | 25 | 0.110 |
Why?
|
| Proprotein Convertases | 1 | 2013 | 28 | 0.110 |
Why?
|
| Cell Adhesion | 3 | 2019 | 1041 | 0.110 |
Why?
|
| Zebrafish | 2 | 1994 | 463 | 0.110 |
Why?
|
| Immunophenotyping | 3 | 2022 | 1732 | 0.110 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2013 | 17 | 0.110 |
Why?
|
| Proto-Oncogenes | 4 | 1990 | 208 | 0.110 |
Why?
|
| Quinolines | 1 | 2017 | 403 | 0.110 |
Why?
|
| Haploinsufficiency | 1 | 2015 | 303 | 0.110 |
Why?
|
| Erlotinib Hydrochloride | 3 | 2012 | 398 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2013 | 621 | 0.110 |
Why?
|
| Drug Synergism | 1 | 2017 | 1364 | 0.110 |
Why?
|
| Loss of Heterozygosity | 3 | 2006 | 626 | 0.110 |
Why?
|
| Ultraviolet Rays | 3 | 2005 | 591 | 0.110 |
Why?
|
| Oncogene Protein v-akt | 2 | 2011 | 102 | 0.110 |
Why?
|
| Hyaluronic Acid | 1 | 2014 | 152 | 0.110 |
Why?
|
| S Phase | 6 | 2001 | 290 | 0.110 |
Why?
|
| HIV Protease Inhibitors | 1 | 2013 | 74 | 0.110 |
Why?
|
| Vertebrates | 1 | 1993 | 63 | 0.110 |
Why?
|
| Ubiquitin | 1 | 2015 | 335 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2003 | 2174 | 0.110 |
Why?
|
| Thrombospondin 1 | 1 | 2013 | 52 | 0.110 |
Why?
|
| Boron Compounds | 1 | 2013 | 69 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 4 | 2017 | 703 | 0.110 |
Why?
|
| Ritonavir | 1 | 2013 | 66 | 0.110 |
Why?
|
| Phosphonoacetic Acid | 1 | 2012 | 19 | 0.110 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 2 | 2011 | 81 | 0.110 |
Why?
|
| Cell Nucleus | 6 | 2008 | 1740 | 0.110 |
Why?
|
| Cluster Analysis | 2 | 2006 | 1074 | 0.110 |
Why?
|
| Zebrafish Proteins | 3 | 2003 | 158 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 384 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 1999 | 1094 | 0.110 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2013 | 70 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2012 | 355 | 0.100 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2014 | 159 | 0.100 |
Why?
|
| Sirtuin 1 | 2 | 2010 | 82 | 0.100 |
Why?
|
| Tissue Distribution | 4 | 2000 | 946 | 0.100 |
Why?
|
| Deoxycytidine | 2 | 2017 | 1378 | 0.100 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2013 | 85 | 0.100 |
Why?
|
| Mitosis | 3 | 2000 | 692 | 0.100 |
Why?
|
| Adiponectin | 1 | 2013 | 164 | 0.100 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2012 | 32 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2018 | 1143 | 0.100 |
Why?
|
| Xenopus laevis | 1 | 1993 | 273 | 0.100 |
Why?
|
| Amelogenesis | 1 | 2012 | 4 | 0.100 |
Why?
|
| Enteroendocrine Cells | 1 | 2012 | 24 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2003 | 1592 | 0.100 |
Why?
|
| Tooth Calcification | 1 | 2012 | 5 | 0.100 |
Why?
|
| Promyelocytic Leukemia Protein | 2 | 2009 | 56 | 0.100 |
Why?
|
| Hydroxamic Acids | 2 | 2012 | 455 | 0.100 |
Why?
|
| Cholesterol | 2 | 2013 | 681 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2003 | 249 | 0.100 |
Why?
|
| Animals, Genetically Modified | 2 | 2011 | 417 | 0.100 |
Why?
|
| Dental Enamel | 1 | 2012 | 18 | 0.100 |
Why?
|
| Bone Neoplasms | 2 | 2017 | 2669 | 0.100 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2012 | 97 | 0.100 |
Why?
|
| Regulatory Factor X Transcription Factors | 2 | 2013 | 21 | 0.100 |
Why?
|
| Hyperglycemia | 3 | 2012 | 350 | 0.100 |
Why?
|
| Sympathetic Nervous System | 1 | 2013 | 160 | 0.100 |
Why?
|
| Drosophila | 2 | 1997 | 911 | 0.100 |
Why?
|
| Receptors, Leptin | 1 | 2012 | 68 | 0.100 |
Why?
|
| Cyclin E | 2 | 2008 | 283 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 6270 | 0.100 |
Why?
|
| Mitochondria, Heart | 1 | 2012 | 77 | 0.100 |
Why?
|
| X-Box Binding Protein 1 | 2 | 2013 | 39 | 0.100 |
Why?
|
| Endothelial Growth Factors | 3 | 2003 | 234 | 0.100 |
Why?
|
| Pyridines | 2 | 2017 | 1312 | 0.100 |
Why?
|
| Ischemia | 2 | 2013 | 408 | 0.100 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 2 | 2002 | 129 | 0.100 |
Why?
|
| Qb-SNARE Proteins | 1 | 2011 | 11 | 0.100 |
Why?
|
| Recombinant Proteins | 6 | 2011 | 3072 | 0.100 |
Why?
|
| Colitis | 2 | 2018 | 344 | 0.100 |
Why?
|
| Lymphokines | 3 | 2003 | 317 | 0.100 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2011 | 41 | 0.100 |
Why?
|
| Membrane Proteins | 4 | 2013 | 2975 | 0.100 |
Why?
|
| Interleukin-6 | 4 | 2011 | 1066 | 0.100 |
Why?
|
| G1 Phase | 7 | 2001 | 306 | 0.100 |
Why?
|
| B7-H1 Antigen | 2 | 2022 | 1075 | 0.100 |
Why?
|
| Hair Color | 2 | 2003 | 22 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2013 | 422 | 0.100 |
Why?
|
| Regeneration | 2 | 2012 | 287 | 0.100 |
Why?
|
| Lipid Metabolism | 4 | 2021 | 498 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 968 | 0.100 |
Why?
|
| Duodenum | 1 | 2012 | 170 | 0.100 |
Why?
|
| Tight Junctions | 2 | 2009 | 61 | 0.100 |
Why?
|
| Organ Size | 2 | 2010 | 727 | 0.100 |
Why?
|
| Eye Proteins | 3 | 2000 | 278 | 0.100 |
Why?
|
| Vesicular Transport Proteins | 1 | 2012 | 149 | 0.100 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2011 | 20 | 0.090 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2011 | 15 | 0.090 |
Why?
|
| Blotting, Northern | 6 | 2001 | 735 | 0.090 |
Why?
|
| Protein Transport | 2 | 2010 | 739 | 0.090 |
Why?
|
| Glucokinase | 2 | 2013 | 23 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 468 | 0.090 |
Why?
|
| Iodide Peroxidase | 1 | 2010 | 25 | 0.090 |
Why?
|
| Glutamine | 1 | 2013 | 328 | 0.090 |
Why?
|
| Imidazoles | 1 | 2017 | 1056 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2013 | 550 | 0.090 |
Why?
|
| Starvation | 1 | 2010 | 26 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2020 | 3176 | 0.090 |
Why?
|
| Superoxide Dismutase | 1 | 2012 | 269 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 5 | 2012 | 512 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2009 | 278 | 0.090 |
Why?
|
| Paired Box Transcription Factors | 2 | 2008 | 133 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 6 | 2008 | 3512 | 0.090 |
Why?
|
| Spermatids | 1 | 2010 | 44 | 0.090 |
Why?
|
| Interleukin-7 | 1 | 2011 | 93 | 0.090 |
Why?
|
| Alopecia | 2 | 2003 | 124 | 0.090 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2010 | 130 | 0.090 |
Why?
|
| Penetrance | 1 | 2011 | 134 | 0.090 |
Why?
|
| Fibrosis | 2 | 2021 | 747 | 0.090 |
Why?
|
| Megakaryocytes | 1 | 2011 | 131 | 0.090 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 642 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 6 | 2001 | 300 | 0.090 |
Why?
|
| Hematopoietic System | 1 | 2010 | 26 | 0.090 |
Why?
|
| Germ Cells | 1 | 2012 | 351 | 0.090 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2003 | 205 | 0.090 |
Why?
|
| Tyrosine | 3 | 2012 | 510 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2010 | 41 | 0.090 |
Why?
|
| Hepatocytes | 2 | 2009 | 351 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2013 | 482 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2017 | 802 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 4 | 2012 | 1599 | 0.090 |
Why?
|
| Tissue Array Analysis | 3 | 2020 | 760 | 0.090 |
Why?
|
| Gene Knockout Techniques | 3 | 2018 | 272 | 0.090 |
Why?
|
| Bone Density | 1 | 2013 | 470 | 0.090 |
Why?
|
| Carboxypeptidase H | 1 | 2009 | 3 | 0.090 |
Why?
|
| Dimerization | 2 | 2002 | 318 | 0.090 |
Why?
|
| Hypoglycemia | 1 | 2011 | 219 | 0.090 |
Why?
|
| Genes, Neoplasm | 2 | 2010 | 317 | 0.090 |
Why?
|
| Binding Sites | 5 | 2013 | 2298 | 0.090 |
Why?
|
| Cholesterol, LDL | 1 | 2013 | 583 | 0.090 |
Why?
|
| Synteny | 2 | 2007 | 81 | 0.090 |
Why?
|
| Dyskeratosis Congenita | 1 | 2009 | 26 | 0.090 |
Why?
|
| Hyperlipidemias | 1 | 2011 | 237 | 0.090 |
Why?
|
| Sertoli Cells | 1 | 2010 | 153 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2020 | 5603 | 0.080 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 249 | 0.080 |
Why?
|
| Leukemia, Erythroblastic, Acute | 3 | 2007 | 123 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2022 | 917 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2000 | 449 | 0.080 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2009 | 92 | 0.080 |
Why?
|
| Electrical Synapses | 1 | 2009 | 9 | 0.080 |
Why?
|
| Mass Spectrometry | 4 | 2015 | 726 | 0.080 |
Why?
|
| Peripheral Arterial Disease | 1 | 2013 | 272 | 0.080 |
Why?
|
| DNA, Complementary | 4 | 2005 | 955 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2009 | 267 | 0.080 |
Why?
|
| Doxycycline | 2 | 2000 | 178 | 0.080 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2010 | 183 | 0.080 |
Why?
|
| Metaplasia | 2 | 2008 | 387 | 0.080 |
Why?
|
| Receptors, CCR7 | 1 | 2009 | 38 | 0.080 |
Why?
|
| Skin | 4 | 2005 | 1284 | 0.080 |
Why?
|
| Genetics, Medical | 1 | 2010 | 141 | 0.080 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2009 | 49 | 0.080 |
Why?
|
| L-Selectin | 1 | 2009 | 36 | 0.080 |
Why?
|
| Receptors, Growth Factor | 2 | 2007 | 159 | 0.080 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2001 | 223 | 0.080 |
Why?
|
| Cell Size | 2 | 2013 | 145 | 0.080 |
Why?
|
| Immunity, Mucosal | 1 | 2009 | 121 | 0.080 |
Why?
|
| Epigenesis, Genetic | 4 | 2023 | 1439 | 0.080 |
Why?
|
| Heart | 2 | 2005 | 1214 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2015 | 6210 | 0.080 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 4 | 2012 | 73 | 0.080 |
Why?
|
| Lipoproteins, LDL | 1 | 2009 | 151 | 0.080 |
Why?
|
| Receptors, Estrogen | 3 | 2012 | 2268 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 3 | 2004 | 61 | 0.080 |
Why?
|
| Xenopus | 2 | 2003 | 237 | 0.080 |
Why?
|
| MyoD Protein | 1 | 2008 | 33 | 0.080 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2008 | 23 | 0.080 |
Why?
|
| Genes, Immunoglobulin Light Chain | 1 | 2008 | 1 | 0.080 |
Why?
|
| Endocrine Glands | 1 | 2008 | 22 | 0.080 |
Why?
|
| Mice, 129 Strain | 3 | 2013 | 163 | 0.080 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2010 | 238 | 0.080 |
Why?
|
| Pseudogenes | 2 | 1991 | 92 | 0.080 |
Why?
|
| International Cooperation | 1 | 2010 | 326 | 0.080 |
Why?
|
| Liver Neoplasms | 2 | 2003 | 4811 | 0.080 |
Why?
|
| Plectin | 1 | 2008 | 3 | 0.080 |
Why?
|
| Oxygen | 2 | 2010 | 800 | 0.080 |
Why?
|
| Oligodendroglia | 2 | 1999 | 112 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2009 | 161 | 0.080 |
Why?
|
| Spleen | 3 | 2000 | 732 | 0.080 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 103 | 0.080 |
Why?
|
| Macrophages, Peritoneal | 1 | 2008 | 76 | 0.080 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2009 | 174 | 0.080 |
Why?
|
| Receptors, Notch | 1 | 2011 | 377 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2013 | 815 | 0.080 |
Why?
|
| Databases, Protein | 1 | 2008 | 101 | 0.080 |
Why?
|
| Gene Transfer Techniques | 3 | 2000 | 813 | 0.080 |
Why?
|
| Kinetics | 2 | 2002 | 2242 | 0.080 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2007 | 33 | 0.080 |
Why?
|
| Growth | 1 | 2008 | 125 | 0.080 |
Why?
|
| Spermatozoa | 2 | 2001 | 324 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2011 | 2576 | 0.080 |
Why?
|
| Models, Molecular | 3 | 2016 | 1756 | 0.070 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 2 | 1998 | 70 | 0.070 |
Why?
|
| Insulin Resistance | 5 | 2012 | 748 | 0.070 |
Why?
|
| Open Reading Frames | 2 | 2002 | 275 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 7 | 2013 | 2470 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2007 | 51 | 0.070 |
Why?
|
| Oncogene Proteins, Viral | 2 | 2004 | 148 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 6 | 2010 | 541 | 0.070 |
Why?
|
| Alu Elements | 1 | 2007 | 90 | 0.070 |
Why?
|
| Food | 1 | 2008 | 156 | 0.070 |
Why?
|
| Dromaiidae | 1 | 2007 | 4 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 1534 | 0.070 |
Why?
|
| Oxidation-Reduction | 3 | 2017 | 718 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2008 | 674 | 0.070 |
Why?
|
| Time Factors | 5 | 2009 | 13130 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2009 | 241 | 0.070 |
Why?
|
| Piperazines | 4 | 2011 | 2152 | 0.070 |
Why?
|
| Pre-B-Cell Leukemia Transcription Factor 1 | 1 | 2007 | 9 | 0.070 |
Why?
|
| Hypergammaglobulinemia | 1 | 2007 | 23 | 0.070 |
Why?
|
| Simplexvirus | 1 | 2008 | 180 | 0.070 |
Why?
|
| Plasma | 1 | 2008 | 147 | 0.070 |
Why?
|
| Crystallins | 3 | 1999 | 30 | 0.070 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2010 | 343 | 0.070 |
Why?
|
| Disease Susceptibility | 2 | 2022 | 545 | 0.070 |
Why?
|
| Adamantane | 1 | 2007 | 21 | 0.070 |
Why?
|
| Aneuploidy | 3 | 2003 | 377 | 0.070 |
Why?
|
| Hydroquinones | 1 | 2007 | 33 | 0.070 |
Why?
|
| Murine hepatitis virus | 1 | 2006 | 2 | 0.070 |
Why?
|
| Muscle, Smooth | 1 | 2008 | 257 | 0.070 |
Why?
|
| Hepatitis, Animal | 1 | 2006 | 5 | 0.070 |
Why?
|
| Tamoxifen | 5 | 2012 | 906 | 0.070 |
Why?
|
| Eating | 1 | 2009 | 449 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 201 | 0.070 |
Why?
|
| Ovary | 2 | 2003 | 701 | 0.070 |
Why?
|
| Receptors, Virus | 2 | 2005 | 153 | 0.070 |
Why?
|
| Stromal Cells | 2 | 2008 | 835 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2007 | 83 | 0.070 |
Why?
|
| Bone Marrow Cells | 2 | 2011 | 983 | 0.070 |
Why?
|
| Blood Cells | 1 | 2007 | 130 | 0.070 |
Why?
|
| Adenosine Triphosphate | 4 | 2011 | 593 | 0.070 |
Why?
|
| Chromosome Mapping | 6 | 2002 | 1650 | 0.070 |
Why?
|
| Cell Polarity | 1 | 2008 | 215 | 0.070 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2011 | 417 | 0.070 |
Why?
|
| Breast Neoplasms | 5 | 2017 | 16242 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2007 | 177 | 0.070 |
Why?
|
| Leukemia, Myeloid | 1 | 2011 | 994 | 0.070 |
Why?
|
| Cytoskeleton | 1 | 2008 | 304 | 0.070 |
Why?
|
| Anaphase | 2 | 2004 | 54 | 0.070 |
Why?
|
| Plasmids | 5 | 2008 | 953 | 0.070 |
Why?
|
| Life Expectancy | 2 | 2004 | 129 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 3 | 2017 | 889 | 0.070 |
Why?
|
| Flow Cytometry | 7 | 2009 | 3078 | 0.070 |
Why?
|
| Down-Regulation | 3 | 2018 | 2106 | 0.070 |
Why?
|
| Oncolytic Viruses | 1 | 2008 | 165 | 0.070 |
Why?
|
| Adenoviridae | 5 | 2008 | 1514 | 0.070 |
Why?
|
| Epithelial Cells | 3 | 2008 | 1892 | 0.070 |
Why?
|
| Diploidy | 1 | 2006 | 116 | 0.070 |
Why?
|
| Glucose Clamp Technique | 3 | 2015 | 91 | 0.070 |
Why?
|
| Bone Diseases | 1 | 2007 | 142 | 0.070 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2011 | 802 | 0.070 |
Why?
|
| Tuberous Sclerosis | 2 | 2004 | 144 | 0.070 |
Why?
|
| Laminin | 2 | 2021 | 214 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2005 | 61 | 0.070 |
Why?
|
| DNA | 6 | 2012 | 3089 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2009 | 621 | 0.060 |
Why?
|
| Naphthalenes | 1 | 2006 | 84 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2007 | 190 | 0.060 |
Why?
|
| Receptor, EphA2 | 1 | 2006 | 139 | 0.060 |
Why?
|
| Gene Duplication | 1 | 2007 | 433 | 0.060 |
Why?
|
| Chromatids | 1 | 2005 | 84 | 0.060 |
Why?
|
| Memory | 1 | 2009 | 443 | 0.060 |
Why?
|
| Nerve Growth Factors | 3 | 2014 | 129 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 352 | 0.060 |
Why?
|
| Proteoglycans | 2 | 2021 | 278 | 0.060 |
Why?
|
| Fluorouracil | 2 | 2001 | 1988 | 0.060 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2010 | 514 | 0.060 |
Why?
|
| Hemangioma | 1 | 2007 | 160 | 0.060 |
Why?
|
| Skin Diseases | 2 | 2007 | 366 | 0.060 |
Why?
|
| Proteomics | 4 | 2020 | 1437 | 0.060 |
Why?
|
| DNA, Neoplasm | 6 | 2002 | 1972 | 0.060 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 3 | 2001 | 57 | 0.060 |
Why?
|
| Blastocyst | 2 | 2003 | 144 | 0.060 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2002 | 155 | 0.060 |
Why?
|
| Macromolecular Substances | 3 | 2002 | 342 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2006 | 298 | 0.060 |
Why?
|
| In Situ Hybridization | 4 | 2005 | 1061 | 0.060 |
Why?
|
| Bloom Syndrome | 1 | 2004 | 10 | 0.060 |
Why?
|
| Aquaporins | 2 | 1995 | 23 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1555 | 0.060 |
Why?
|
| Blood Glucose | 5 | 2011 | 1286 | 0.060 |
Why?
|
| Transformation, Genetic | 2 | 2002 | 70 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2008 | 754 | 0.060 |
Why?
|
| Castleman Disease | 1 | 2005 | 72 | 0.060 |
Why?
|
| Chromosomes, Human | 1 | 2006 | 290 | 0.060 |
Why?
|
| Heat-Shock Proteins | 3 | 2012 | 339 | 0.060 |
Why?
|
| Cytogenetics | 1 | 2005 | 152 | 0.060 |
Why?
|
| Nevus | 1 | 2005 | 117 | 0.060 |
Why?
|
| Hyperplasia | 1 | 2006 | 581 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2006 | 569 | 0.060 |
Why?
|
| Aging, Premature | 1 | 2004 | 39 | 0.060 |
Why?
|
| Erythropoietin | 1 | 2005 | 219 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 2 | 2008 | 1209 | 0.060 |
Why?
|
| Drug Combinations | 2 | 2021 | 636 | 0.060 |
Why?
|
| Virus Replication | 1 | 2008 | 773 | 0.060 |
Why?
|
| Histone Acetyltransferases | 1 | 2006 | 442 | 0.060 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 1 | 2004 | 64 | 0.060 |
Why?
|
| Caspases | 1 | 2007 | 687 | 0.060 |
Why?
|
| CD4 Antigens | 2 | 2010 | 171 | 0.060 |
Why?
|
| Exodeoxyribonucleases | 1 | 2004 | 109 | 0.060 |
Why?
|
| Endodeoxyribonucleases | 1 | 2004 | 115 | 0.060 |
Why?
|
| Pyrimidinones | 1 | 2006 | 317 | 0.060 |
Why?
|
| Methyltransferases | 1 | 2005 | 153 | 0.060 |
Why?
|
| Proviruses | 2 | 2002 | 24 | 0.060 |
Why?
|
| Unfolded Protein Response | 2 | 2015 | 114 | 0.060 |
Why?
|
| Follicular Atresia | 1 | 2003 | 3 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2008 | 909 | 0.060 |
Why?
|
| Superovulation | 1 | 2003 | 14 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 349 | 0.060 |
Why?
|
| Hamartoma | 1 | 2004 | 89 | 0.060 |
Why?
|
| Sexual Maturation | 1 | 2003 | 67 | 0.050 |
Why?
|
| DNA, Fungal | 2 | 2001 | 148 | 0.050 |
Why?
|
| Chromosome Painting | 1 | 2003 | 24 | 0.050 |
Why?
|
| Growth Substances | 2 | 2001 | 329 | 0.050 |
Why?
|
| Congenital Abnormalities | 2 | 2004 | 281 | 0.050 |
Why?
|
| Obesity | 3 | 2012 | 2958 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2005 | 325 | 0.050 |
Why?
|
| Collagen | 2 | 2021 | 739 | 0.050 |
Why?
|
| RNA Polymerase II | 2 | 1995 | 186 | 0.050 |
Why?
|
| Cisplatin | 2 | 2020 | 2497 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2008 | 586 | 0.050 |
Why?
|
| Luteinizing Hormone | 1 | 2003 | 186 | 0.050 |
Why?
|
| Luminescent Measurements | 1 | 2003 | 159 | 0.050 |
Why?
|
| Tetracycline | 2 | 2000 | 106 | 0.050 |
Why?
|
| Spinal Cord Dorsal Horn | 1 | 2022 | 12 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2005 | 265 | 0.050 |
Why?
|
| Gene Regulatory Networks | 3 | 2015 | 681 | 0.050 |
Why?
|
| Zinc Fingers | 2 | 2007 | 224 | 0.050 |
Why?
|
| Genes, erbB-1 | 1 | 2003 | 104 | 0.050 |
Why?
|
| Cadherins | 1 | 2006 | 676 | 0.050 |
Why?
|
| Cocarcinogenesis | 1 | 2002 | 56 | 0.050 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2003 | 65 | 0.050 |
Why?
|
| Moloney murine leukemia virus | 1 | 2002 | 36 | 0.050 |
Why?
|
| Child | 2 | 2020 | 30499 | 0.050 |
Why?
|
| Receptors, Presynaptic | 1 | 2022 | 27 | 0.050 |
Why?
|
| Oligodendroglioma | 1 | 2003 | 106 | 0.050 |
Why?
|
| Xenopus Proteins | 1 | 2003 | 193 | 0.050 |
Why?
|
| Ovulation | 1 | 2003 | 121 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2003 | 259 | 0.050 |
Why?
|
| Granulosa Cells | 1 | 2003 | 156 | 0.050 |
Why?
|
| Point Mutation | 1 | 1995 | 793 | 0.050 |
Why?
|
| Genes, erbB-2 | 1 | 2003 | 228 | 0.050 |
Why?
|
| Genetic Vectors | 4 | 2000 | 1887 | 0.050 |
Why?
|
| Neoplasm Staging | 4 | 2011 | 13993 | 0.050 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2002 | 65 | 0.050 |
Why?
|
| Mice, Inbred CBA | 1 | 2002 | 83 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 257 | 0.050 |
Why?
|
| Mitogens | 2 | 2001 | 81 | 0.050 |
Why?
|
| Sulfonamides | 2 | 2011 | 1919 | 0.050 |
Why?
|
| Cell Transformation, Viral | 2 | 2003 | 175 | 0.050 |
Why?
|
| United States | 3 | 2017 | 16053 | 0.050 |
Why?
|
| Urethane | 1 | 2001 | 15 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2000 | 253 | 0.050 |
Why?
|
| Animals, Newborn | 4 | 2010 | 1396 | 0.050 |
Why?
|
| Indoles | 1 | 2007 | 1034 | 0.050 |
Why?
|
| Ligases | 1 | 2002 | 85 | 0.050 |
Why?
|
| Ovarian Neoplasms | 2 | 2017 | 4797 | 0.050 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2002 | 94 | 0.050 |
Why?
|
| Mammals | 1 | 2003 | 374 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2011 | 156 | 0.050 |
Why?
|
| Infertility, Female | 1 | 2003 | 210 | 0.050 |
Why?
|
| Granulocytes | 1 | 2002 | 243 | 0.050 |
Why?
|
| Metformin | 1 | 2005 | 395 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2009 | 1331 | 0.050 |
Why?
|
| Biomarkers | 2 | 2022 | 5114 | 0.050 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 2307 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2007 | 732 | 0.050 |
Why?
|
| Myocardium | 3 | 2011 | 1252 | 0.050 |
Why?
|
| Potassium Channels | 2 | 1999 | 196 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 4968 | 0.050 |
Why?
|
| Base Pair Mismatch | 1 | 2001 | 82 | 0.050 |
Why?
|
| Saccharomycetales | 1 | 2001 | 47 | 0.050 |
Why?
|
| Swimming | 1 | 2021 | 31 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 307 | 0.050 |
Why?
|
| Body Weight | 2 | 2012 | 1335 | 0.050 |
Why?
|
| Calcitriol | 1 | 2021 | 146 | 0.050 |
Why?
|
| Rod Opsins | 1 | 2000 | 21 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 620 | 0.050 |
Why?
|
| Middle Aged | 5 | 2020 | 90427 | 0.050 |
Why?
|
| Retinol-Binding Proteins | 1 | 2000 | 31 | 0.050 |
Why?
|
| Sensory Receptor Cells | 1 | 2022 | 155 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2000 | 296 | 0.050 |
Why?
|
| Ganglia, Spinal | 1 | 2022 | 255 | 0.050 |
Why?
|
| Activating Transcription Factor 4 | 2 | 2012 | 80 | 0.050 |
Why?
|
| Terpenes | 1 | 2001 | 40 | 0.050 |
Why?
|
| Protein Isoforms | 3 | 2009 | 860 | 0.050 |
Why?
|
| Oocytes | 1 | 2003 | 422 | 0.050 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2002 | 165 | 0.050 |
Why?
|
| Cyclin A | 1 | 2000 | 50 | 0.050 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2000 | 37 | 0.050 |
Why?
|
| Texas | 1 | 2012 | 6435 | 0.050 |
Why?
|
| Ecdysterone | 1 | 2000 | 6 | 0.050 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 151 | 0.050 |
Why?
|
| Medical Oncology | 2 | 2021 | 1463 | 0.050 |
Why?
|
| Sarcoma, Experimental | 1 | 2000 | 68 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 1842 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2022 | 485 | 0.040 |
Why?
|
| Beckwith-Wiedemann Syndrome | 2 | 1998 | 38 | 0.040 |
Why?
|
| Chemokines | 1 | 2001 | 296 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2007 | 908 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2021 | 163 | 0.040 |
Why?
|
| NAD | 2 | 2011 | 88 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 2 | 1991 | 87 | 0.040 |
Why?
|
| Chromosome Banding | 2 | 1998 | 280 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2014 | 16610 | 0.040 |
Why?
|
| Carcinogens | 1 | 2001 | 398 | 0.040 |
Why?
|
| Cell Transplantation | 1 | 2000 | 89 | 0.040 |
Why?
|
| Young Adult | 1 | 2019 | 22127 | 0.040 |
Why?
|
| Viruses | 1 | 2021 | 156 | 0.040 |
Why?
|
| HeLa Cells | 4 | 2005 | 1718 | 0.040 |
Why?
|
| Epitopes | 1 | 2002 | 708 | 0.040 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 1999 | 29 | 0.040 |
Why?
|
| Receptor, ErbB-2 | 2 | 2009 | 2649 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 269 | 0.040 |
Why?
|
| Plasmacytoma | 1 | 2001 | 123 | 0.040 |
Why?
|
| Fetal Death | 1 | 2000 | 134 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2000 | 128 | 0.040 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2020 | 120 | 0.040 |
Why?
|
| Protein Splicing | 1 | 1999 | 3 | 0.040 |
Why?
|
| Doxorubicin | 2 | 2011 | 3131 | 0.040 |
Why?
|
| Heart Failure | 1 | 2013 | 2500 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1995 | 641 | 0.040 |
Why?
|
| Fumarate Hydratase | 1 | 2019 | 13 | 0.040 |
Why?
|
| Adult | 4 | 2019 | 81889 | 0.040 |
Why?
|
| Rhabdomyosarcoma | 1 | 2002 | 343 | 0.040 |
Why?
|
| Abelson murine leukemia virus | 1 | 1998 | 1 | 0.040 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2002 | 770 | 0.040 |
Why?
|
| Circadian Rhythm | 2 | 2012 | 330 | 0.040 |
Why?
|
| Triglycerides | 2 | 2012 | 622 | 0.040 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1999 | 154 | 0.040 |
Why?
|
| Blood Proteins | 2 | 2011 | 301 | 0.040 |
Why?
|
| Escherichia coli Infections | 1 | 2021 | 271 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2000 | 751 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2021 | 356 | 0.040 |
Why?
|
| Liver Failure, Acute | 1 | 2000 | 98 | 0.040 |
Why?
|
| Mesencephalon | 1 | 2018 | 58 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 1212 | 0.040 |
Why?
|
| Chromosome Disorders | 1 | 2001 | 425 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2006 | 1033 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 1998 | 120 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1999 | 102 | 0.040 |
Why?
|
| Etoposide | 1 | 2001 | 905 | 0.040 |
Why?
|
| Eukaryotic Cells | 1 | 1998 | 52 | 0.040 |
Why?
|
| Dopaminergic Neurons | 1 | 2018 | 53 | 0.040 |
Why?
|
| Cell Death | 2 | 2003 | 689 | 0.040 |
Why?
|
| Karyotyping | 1 | 2000 | 1064 | 0.040 |
Why?
|
| Forecasting | 2 | 2017 | 706 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2008 | 673 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 1998 | 337 | 0.040 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2018 | 81 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 4 | 1999 | 61 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1998 | 252 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 164 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2021 | 334 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 155 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 1998 | 529 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 1997 | 56 | 0.040 |
Why?
|
| Bone Marrow Diseases | 1 | 1999 | 187 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 1999 | 452 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2021 | 392 | 0.040 |
Why?
|
| Nucleotides | 1 | 2018 | 175 | 0.040 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2017 | 64 | 0.040 |
Why?
|
| Staurosporine | 1 | 2018 | 149 | 0.040 |
Why?
|
| Receptor, Insulin | 2 | 2008 | 111 | 0.040 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 2 | 2011 | 24 | 0.040 |
Why?
|
| Splicing Factor U2AF | 1 | 2017 | 44 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 550 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2017 | 9325 | 0.040 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2017 | 44 | 0.040 |
Why?
|
| Cell Hypoxia | 2 | 2010 | 353 | 0.040 |
Why?
|
| Recurrence | 2 | 2017 | 4887 | 0.040 |
Why?
|
| Oncogene Protein p55(v-myc) | 1 | 2017 | 19 | 0.040 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2011 | 62 | 0.040 |
Why?
|
| Enzyme Assays | 1 | 2017 | 24 | 0.040 |
Why?
|
| Anxiety | 2 | 2018 | 1230 | 0.040 |
Why?
|
| PAX3 Transcription Factor | 2 | 2008 | 36 | 0.040 |
Why?
|
| PAX6 Transcription Factor | 1 | 2016 | 53 | 0.040 |
Why?
|
| Aged | 3 | 2019 | 73494 | 0.040 |
Why?
|
| Cell Transdifferentiation | 1 | 2018 | 117 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2009 | 593 | 0.040 |
Why?
|
| Dopamine | 1 | 2018 | 341 | 0.030 |
Why?
|
| Adenovirus E1A Proteins | 2 | 1995 | 165 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 5105 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2000 | 1278 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2017 | 143 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2005 | 1699 | 0.030 |
Why?
|
| SMARCB1 Protein | 1 | 2017 | 109 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2013 | 2337 | 0.030 |
Why?
|
| Cell Separation | 1 | 2018 | 616 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2018 | 312 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2017 | 148 | 0.030 |
Why?
|
| Aphakia | 1 | 1996 | 9 | 0.030 |
Why?
|
| Cell Growth Processes | 2 | 2007 | 340 | 0.030 |
Why?
|
| Lymphoma, B-Cell | 2 | 2000 | 936 | 0.030 |
Why?
|
| Homologous Recombination | 1 | 2017 | 187 | 0.030 |
Why?
|
| Mammary Glands, Animal | 1 | 2000 | 635 | 0.030 |
Why?
|
| Mice, Obese | 2 | 2006 | 97 | 0.030 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1995 | 49 | 0.030 |
Why?
|
| Mice, Congenic | 2 | 2009 | 31 | 0.030 |
Why?
|
| Lentivirus | 1 | 2016 | 166 | 0.030 |
Why?
|
| Antioxidants | 2 | 2010 | 523 | 0.030 |
Why?
|
| Adenylate Kinase | 1 | 2015 | 36 | 0.030 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1995 | 56 | 0.030 |
Why?
|
| Collagen Type II | 1 | 2015 | 38 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 195 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 1590 | 0.030 |
Why?
|
| Microfilament Proteins | 2 | 2008 | 498 | 0.030 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2002 | 917 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 532 | 0.030 |
Why?
|
| Genetic Complementation Test | 2 | 2010 | 148 | 0.030 |
Why?
|
| Precipitin Tests | 2 | 1992 | 360 | 0.030 |
Why?
|
| Epigenomics | 1 | 2016 | 268 | 0.030 |
Why?
|
| Alternative Splicing | 2 | 2009 | 613 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2016 | 282 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2021 | 1309 | 0.030 |
Why?
|
| Kidney | 3 | 2003 | 2267 | 0.030 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2015 | 237 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2010 | 2256 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 203 | 0.030 |
Why?
|
| Mosaicism | 1 | 2017 | 293 | 0.030 |
Why?
|
| Gene Rearrangement | 3 | 2011 | 817 | 0.030 |
Why?
|
| Transgenes | 2 | 2010 | 589 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2015 | 168 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2014 | 54 | 0.030 |
Why?
|
| Hydroxylation | 1 | 2014 | 60 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2003 | 6987 | 0.030 |
Why?
|
| Motor Activity | 1 | 2018 | 718 | 0.030 |
Why?
|
| Leucine Zippers | 1 | 1994 | 41 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1995 | 341 | 0.030 |
Why?
|
| Depression | 2 | 2018 | 1736 | 0.030 |
Why?
|
| Autonomic Fibers, Postganglionic | 1 | 2014 | 5 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 473 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2014 | 51 | 0.030 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2014 | 39 | 0.030 |
Why?
|
| Ganglia, Sympathetic | 1 | 2014 | 34 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2006 | 10259 | 0.030 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2013 | 17 | 0.030 |
Why?
|
| Gene Silencing | 2 | 2010 | 834 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2014 | 165 | 0.030 |
Why?
|
| Trout | 1 | 1993 | 2 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2013 | 44 | 0.030 |
Why?
|
| raf Kinases | 1 | 2013 | 80 | 0.030 |
Why?
|
| Dystrophin | 1 | 2013 | 48 | 0.030 |
Why?
|
| Glutamate Dehydrogenase | 1 | 2013 | 14 | 0.030 |
Why?
|
| Chromosome Fragile Sites | 1 | 2013 | 38 | 0.030 |
Why?
|
| Locus Coeruleus | 1 | 2013 | 33 | 0.030 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2013 | 40 | 0.030 |
Why?
|
| Age Factors | 3 | 2012 | 5521 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2013 | 107 | 0.030 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2013 | 31 | 0.030 |
Why?
|
| HIV-1 | 1 | 1997 | 641 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 2014 | 130 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 1827 | 0.030 |
Why?
|
| Hominidae | 1 | 1993 | 43 | 0.030 |
Why?
|
| Sirolimus | 2 | 2013 | 833 | 0.030 |
Why?
|
| Hindlimb | 1 | 2013 | 112 | 0.030 |
Why?
|
| Hepatectomy | 1 | 2000 | 1013 | 0.030 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2013 | 70 | 0.030 |
Why?
|
| Proprotein Convertase 9 | 1 | 2013 | 70 | 0.030 |
Why?
|
| Fishes | 1 | 1993 | 55 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2013 | 123 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 286 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2013 | 148 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2012 | 10 | 0.030 |
Why?
|
| Ligation | 1 | 2013 | 208 | 0.030 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2012 | 20 | 0.030 |
Why?
|
| Citric Acid Cycle | 1 | 2013 | 94 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 202 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2012 | 74 | 0.030 |
Why?
|
| Autophagy-Related Proteins | 1 | 2012 | 55 | 0.030 |
Why?
|
| MEF2 Transcription Factors | 1 | 2012 | 43 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 554 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2012 | 48 | 0.030 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2012 | 38 | 0.030 |
Why?
|
| Uncoupling Protein 1 | 1 | 2012 | 32 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 211 | 0.030 |
Why?
|
| Hardness Tests | 1 | 2012 | 4 | 0.030 |
Why?
|
| Tooth Diseases | 1 | 2012 | 5 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1992 | 148 | 0.030 |
Why?
|
| Chickens | 1 | 1993 | 791 | 0.030 |
Why?
|
| Catecholamines | 1 | 2012 | 100 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 3 | 1999 | 212 | 0.030 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2013 | 64 | 0.030 |
Why?
|
| Mice, Inbred DBA | 2 | 2003 | 119 | 0.030 |
Why?
|
| Sulfonylurea Compounds | 1 | 2012 | 34 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 1998 | 619 | 0.030 |
Why?
|
| Ki-67 Antigen | 2 | 2005 | 685 | 0.030 |
Why?
|
| Embryonic Development | 1 | 1994 | 315 | 0.030 |
Why?
|
| Introns | 1 | 1993 | 461 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2013 | 204 | 0.030 |
Why?
|
| Calcification, Physiologic | 1 | 2012 | 55 | 0.030 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2013 | 84 | 0.030 |
Why?
|
| Blotting, Southern | 2 | 2008 | 455 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 1992 | 142 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 1020 | 0.030 |
Why?
|
| Streptozocin | 1 | 2012 | 72 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 1248 | 0.020 |
Why?
|
| C-Peptide | 1 | 2012 | 117 | 0.020 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 2011 | 52 | 0.020 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2011 | 11 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2012 | 196 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2011 | 59 | 0.020 |
Why?
|
| Transcription Factor 4 | 1 | 2011 | 34 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2007 | 339 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2013 | 350 | 0.020 |
Why?
|
| Thrombopoiesis | 1 | 2011 | 23 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2012 | 86 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 397 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2012 | 125 | 0.020 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 1991 | 41 | 0.020 |
Why?
|
| Transcription Factor DP1 | 2 | 2001 | 59 | 0.020 |
Why?
|
| Enzyme Reactivators | 1 | 2010 | 4 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2011 | 81 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2000 | 1184 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 250 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1997 | 1015 | 0.020 |
Why?
|
| Oxidants | 1 | 2010 | 51 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2006 | 504 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 1995 | 735 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 591 | 0.020 |
Why?
|
| Ion Channels | 1 | 2012 | 241 | 0.020 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2010 | 26 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 423 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2010 | 49 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2010 | 84 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2013 | 269 | 0.020 |
Why?
|
| Wnt1 Protein | 1 | 2010 | 102 | 0.020 |
Why?
|
| Nitrophenols | 1 | 2011 | 95 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2010 | 40 | 0.020 |
Why?
|
| Intellectual Property | 1 | 2010 | 10 | 0.020 |
Why?
|
| Pyrimidines | 2 | 2017 | 3664 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 254 | 0.020 |
Why?
|
| Lac Operon | 2 | 2000 | 135 | 0.020 |
Why?
|
| Incidence | 1 | 2000 | 5861 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 94 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 304 | 0.020 |
Why?
|
| Pancytopenia | 1 | 2010 | 119 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2010 | 44 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2010 | 82 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 238 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1991 | 211 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2008 | 7929 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 196 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2011 | 253 | 0.020 |
Why?
|
| E2F1 Transcription Factor | 2 | 2001 | 201 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 225 | 0.020 |
Why?
|
| alpha-MSH | 1 | 2009 | 16 | 0.020 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2009 | 26 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2002 | 570 | 0.020 |
Why?
|
| beta-Endorphin | 1 | 2009 | 43 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2012 | 385 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2011 | 192 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2010 | 170 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2010 | 320 | 0.020 |
Why?
|
| Smell | 1 | 2010 | 133 | 0.020 |
Why?
|
| Arenaviridae Infections | 1 | 2009 | 4 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2010 | 88 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2011 | 643 | 0.020 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2009 | 26 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2009 | 60 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2010 | 69 | 0.020 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2009 | 52 | 0.020 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2011 | 289 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 128 | 0.020 |
Why?
|
| Adipokines | 1 | 2009 | 99 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 641 | 0.020 |
Why?
|
| Fetus | 2 | 2005 | 674 | 0.020 |
Why?
|
| COS Cells | 1 | 2009 | 423 | 0.020 |
Why?
|
| Survival Rate | 1 | 2003 | 12533 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1991 | 615 | 0.020 |
Why?
|
| Niacinamide | 1 | 2011 | 427 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2010 | 158 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 245 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 347 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2009 | 161 | 0.020 |
Why?
|
| Butyrates | 1 | 2009 | 58 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2011 | 317 | 0.020 |
Why?
|
| Dendritic Spines | 1 | 2009 | 58 | 0.020 |
Why?
|
| Fenfluramine | 1 | 2008 | 13 | 0.020 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2008 | 47 | 0.020 |
Why?
|
| Body Composition | 1 | 2012 | 609 | 0.020 |
Why?
|
| Somatostatin | 1 | 2009 | 119 | 0.020 |
Why?
|
| Permeability | 1 | 2009 | 162 | 0.020 |
Why?
|
| Imipramine | 1 | 2008 | 33 | 0.020 |
Why?
|
| Serotonin Agents | 1 | 2008 | 19 | 0.020 |
Why?
|
| Burkitt Lymphoma | 2 | 2006 | 350 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2009 | 81 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2009 | 106 | 0.020 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2008 | 38 | 0.020 |
Why?
|
| Myoblasts | 1 | 2008 | 64 | 0.020 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2008 | 85 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2008 | 21 | 0.020 |
Why?
|
| Jagged-1 Protein | 1 | 2008 | 103 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2009 | 289 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 2009 | 248 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2011 | 448 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2008 | 92 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2008 | 210 | 0.020 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2007 | 23 | 0.020 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2007 | 23 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2008 | 186 | 0.020 |
Why?
|
| Ligands | 1 | 2010 | 1057 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2010 | 331 | 0.020 |
Why?
|
| Sodium | 1 | 2009 | 355 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 188 | 0.020 |
Why?
|
| Food Deprivation | 1 | 2007 | 48 | 0.020 |
Why?
|
| Peptide Library | 1 | 2008 | 165 | 0.020 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 319 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 286 | 0.020 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2007 | 23 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2009 | 276 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2011 | 600 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2018 | 3080 | 0.020 |
Why?
|
| Apoptosomes | 1 | 2007 | 12 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 138 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2007 | 117 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2011 | 869 | 0.020 |
Why?
|
| Transcription Factor HES-1 | 1 | 2006 | 48 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2010 | 580 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2007 | 262 | 0.020 |
Why?
|
| Hippocampus | 2 | 2009 | 976 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 5195 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2007 | 100 | 0.020 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2008 | 160 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 1995 | 1076 | 0.020 |
Why?
|
| Sirtuin 2 | 1 | 2006 | 18 | 0.020 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2006 | 3 | 0.020 |
Why?
|
| Spectral Karyotyping | 1 | 2006 | 16 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2009 | 347 | 0.020 |
Why?
|
| Monophenol Monooxygenase | 1 | 2006 | 60 | 0.020 |
Why?
|
| Lectins | 1 | 2006 | 152 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2007 | 188 | 0.020 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2006 | 67 | 0.020 |
Why?
|
| Werner Syndrome Helicase | 1 | 2005 | 12 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2006 | 126 | 0.020 |
Why?
|
| Sp1 Transcription Factor | 1 | 2007 | 193 | 0.020 |
Why?
|
| Dexamethasone | 2 | 2007 | 1497 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2005 | 33 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 245 | 0.020 |
Why?
|
| Molecular Probe Techniques | 1 | 2005 | 47 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 557 | 0.020 |
Why?
|
| Tubulin | 1 | 2006 | 203 | 0.020 |
Why?
|
| Genes | 1 | 1987 | 613 | 0.020 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2006 | 111 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 6236 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 560 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2007 | 249 | 0.020 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2005 | 40 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2005 | 76 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 524 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 391 | 0.020 |
Why?
|
| Oncolytic Virotherapy | 1 | 2008 | 235 | 0.020 |
Why?
|
| Biopsy | 1 | 2013 | 3544 | 0.020 |
Why?
|
| Learning | 1 | 2009 | 432 | 0.020 |
Why?
|
| Carotid Stenosis | 1 | 2007 | 160 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 684 | 0.020 |
Why?
|
| HIV Infections | 1 | 1997 | 2157 | 0.020 |
Why?
|
| Rabbits | 1 | 2007 | 1077 | 0.020 |
Why?
|
| Immunoglobulin Heavy Chains | 3 | 1991 | 242 | 0.020 |
Why?
|
| Placenta | 3 | 1998 | 565 | 0.020 |
Why?
|
| RecQ Helicases | 1 | 2005 | 95 | 0.020 |
Why?
|
| Perfusion | 1 | 2006 | 285 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2007 | 355 | 0.020 |
Why?
|
| Bortezomib | 1 | 2007 | 542 | 0.020 |
Why?
|
| Hybridization, Genetic | 1 | 2004 | 26 | 0.020 |
Why?
|
| Body Constitution | 1 | 2004 | 39 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2010 | 872 | 0.020 |
Why?
|
| Catalysis | 1 | 2005 | 246 | 0.020 |
Why?
|
| CTLA-4 Antigen | 1 | 2009 | 681 | 0.020 |
Why?
|
| LLC-PK1 Cells | 1 | 2004 | 9 | 0.010 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2004 | 67 | 0.010 |
Why?
|
| Physical Conditioning, Animal | 1 | 2005 | 116 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 636 | 0.010 |
Why?
|
| Wilms Tumor | 1 | 1987 | 302 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2004 | 123 | 0.010 |
Why?
|
| Anemia | 1 | 2010 | 730 | 0.010 |
Why?
|
| Risk Factors | 2 | 2013 | 18047 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 1054 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 2365 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 2004 | 124 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2009 | 1436 | 0.010 |
Why?
|
| Pyrazines | 1 | 2007 | 513 | 0.010 |
Why?
|
| Melphalan | 1 | 2007 | 875 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2003 | 39 | 0.010 |
Why?
|
| Threonine | 1 | 2004 | 165 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2006 | 457 | 0.010 |
Why?
|
| Oncogene Proteins v-erbB | 1 | 2003 | 4 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 1501 | 0.010 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2003 | 20 | 0.010 |
Why?
|
| Infertility | 1 | 2004 | 106 | 0.010 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2003 | 148 | 0.010 |
Why?
|
| Body Patterning | 1 | 2003 | 209 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2007 | 1140 | 0.010 |
Why?
|
| S100 Proteins | 1 | 2003 | 190 | 0.010 |
Why?
|
| Imatinib Mesylate | 1 | 2007 | 1690 | 0.010 |
Why?
|
| Pigmentation | 1 | 2002 | 52 | 0.010 |
Why?
|
| Adolescent | 1 | 2003 | 32687 | 0.010 |
Why?
|
| Albumins | 1 | 2003 | 267 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2001 | 35 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 1304 | 0.010 |
Why?
|
| Colonic Polyps | 1 | 2004 | 221 | 0.010 |
Why?
|
| tau Proteins | 1 | 2003 | 213 | 0.010 |
Why?
|
| Papilloma | 1 | 2001 | 88 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 900 | 0.010 |
Why?
|
| Pregnancy | 3 | 2006 | 8100 | 0.010 |
Why?
|
| E2F6 Transcription Factor | 1 | 2001 | 10 | 0.010 |
Why?
|
| E2F3 Transcription Factor | 1 | 2001 | 23 | 0.010 |
Why?
|
| Benzamides | 1 | 2007 | 1882 | 0.010 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2001 | 38 | 0.010 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2001 | 22 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2004 | 668 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2001 | 237 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2003 | 485 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2001 | 233 | 0.010 |
Why?
|
| cdc25 Phosphatases | 1 | 2001 | 101 | 0.010 |
Why?
|
| Ecdysteroids | 1 | 2000 | 2 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2006 | 1772 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2001 | 206 | 0.010 |
Why?
|
| Concanavalin A | 1 | 2000 | 64 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2000 | 278 | 0.010 |
Why?
|
| Meiosis | 1 | 2001 | 185 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2000 | 89 | 0.010 |
Why?
|
| Cyprinodontiformes | 1 | 2000 | 4 | 0.010 |
Why?
|
| Tetracycline Resistance | 1 | 1999 | 8 | 0.010 |
Why?
|
| Opossums | 1 | 2000 | 26 | 0.010 |
Why?
|
| CD40 Antigens | 1 | 2001 | 107 | 0.010 |
Why?
|
| Ku Autoantigen | 1 | 2000 | 83 | 0.010 |
Why?
|
| Interphase | 1 | 2000 | 156 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2001 | 291 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1986 | 1136 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2000 | 238 | 0.010 |
Why?
|
| Mesocricetus | 1 | 2000 | 119 | 0.010 |
Why?
|
| Tetraethylammonium | 1 | 1999 | 16 | 0.010 |
Why?
|
| Veratridine | 1 | 1999 | 6 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 39800 | 0.010 |
Why?
|
| Cyclin D | 1 | 1999 | 40 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1999 | 41 | 0.010 |
Why?
|
| Colforsin | 1 | 1999 | 68 | 0.010 |
Why?
|
| Deferoxamine | 1 | 1999 | 29 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 1610 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1999 | 192 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2000 | 321 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1999 | 135 | 0.010 |
Why?
|
| Graft Survival | 1 | 2003 | 1092 | 0.010 |
Why?
|
| Cyclin D2 | 1 | 1999 | 41 | 0.010 |
Why?
|
| Potassium Channel Blockers | 1 | 1999 | 114 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2000 | 374 | 0.010 |
Why?
|
| Cricetinae | 1 | 2000 | 793 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 2002 | 313 | 0.010 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 1998 | 11 | 0.010 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 1999 | 87 | 0.010 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 1998 | 18 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 1998 | 86 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 2000 | 356 | 0.010 |
Why?
|
| Ion Channel Gating | 1 | 1999 | 151 | 0.010 |
Why?
|
| Clone Cells | 1 | 1999 | 589 | 0.010 |
Why?
|
| Steroids | 1 | 2000 | 375 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 7258 | 0.010 |
Why?
|
| Mating Factor | 1 | 1997 | 8 | 0.010 |
Why?
|
| Potassium | 1 | 1999 | 349 | 0.010 |
Why?
|
| Biotin | 1 | 1998 | 79 | 0.010 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 1997 | 32 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 1997 | 24 | 0.010 |
Why?
|
| Syndrome | 1 | 2001 | 1405 | 0.010 |
Why?
|
| Pheromones | 1 | 1997 | 27 | 0.010 |
Why?
|
| Computational Biology | 1 | 2004 | 1282 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 1998 | 219 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2000 | 593 | 0.010 |
Why?
|
| Neutrophils | 1 | 2002 | 876 | 0.010 |
Why?
|
| Kidney Medulla | 1 | 1997 | 42 | 0.010 |
Why?
|
| Adrenal Cortex | 1 | 1997 | 38 | 0.010 |
Why?
|
| Biological Transport | 1 | 1999 | 645 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 347 | 0.010 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2000 | 404 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2002 | 532 | 0.010 |
Why?
|
| Hernia, Umbilical | 1 | 1997 | 43 | 0.010 |
Why?
|
| Cartilage | 1 | 1997 | 112 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1998 | 466 | 0.010 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 1997 | 190 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 1997 | 268 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 1998 | 280 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1998 | 413 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 10365 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 1995 | 27 | 0.010 |
Why?
|
| Cerebellum | 1 | 1999 | 476 | 0.010 |
Why?
|
| Abdomen | 1 | 1997 | 348 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1995 | 223 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 13936 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2005 | 1781 | 0.010 |
Why?
|
| Transcription Factor Brn-3A | 1 | 1992 | 10 | 0.010 |
Why?
|
| Genomic Library | 1 | 1992 | 58 | 0.010 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 1992 | 36 | 0.010 |
Why?
|
| DNA Probes | 1 | 1992 | 248 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2001 | 2157 | 0.010 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1991 | 7 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 1991 | 12 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 31060 | 0.010 |
Why?
|
| Crossing Over, Genetic | 1 | 1991 | 65 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1991 | 139 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1991 | 169 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1991 | 278 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1991 | 298 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1991 | 406 | 0.010 |
Why?
|
| Teratoma | 1 | 1991 | 253 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2010 | 33874 | 0.000 |
Why?
|
| Sarcoma, Ewing | 1 | 1992 | 426 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 162 | 0.000 |
Why?
|
| RNA, Neoplasm | 1 | 1990 | 810 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1986 | 611 | 0.000 |
Why?
|
| Antigens, Surface | 1 | 1986 | 311 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1986 | 683 | 0.000 |
Why?
|
| Carcinoma | 1 | 1995 | 2623 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1986 | 4496 | 0.000 |
Why?
|